FBLG

Conviction 62HealthcareScan · Thu, Jun 25, 2026

FBLG$0.7450-3.17%

ResistanceSupportVol 14

Vol MA14 140.89K

Mar 26Apr 14May 1May 19Jun 8Jun 25

FibroBiologics, Inc.PHARMACEUTICAL PREPARATIONSwww.fibrobiologics.com ↗

Price0.7450

Change-3.17%

Gap+0.08%

Rel volume0.40×

Avg volume146.78K

Avg $ vol136.73K

SMA 200.9381

SMA 501.14

SMA 2000.6116

Price vs 50-34.67%

Price vs 200+21.82%

MA stackmixed

50/200 cross—

Supertrenddown · 0.9970

RSI (14)30

MACD hist-0.02

MACD cross—

Stoch %K / %D4 / 4

ADX (14)18

+DI / −DI14 / 23

RSI divergence—

MACD divergenceBullish

ATR %+12.26%

ADR %9.00%

52w high2.28

52w low0.1966

From 52w high-67.32%

Above 52w low+278.94%

New 52w highNo

SqueezeOff

Bollinger width57.64%

%B0.14

Donchian pos3.17%

Donchian high1.17

Donchian low0.7311

AVWAP (52w high)1.37

vs AVWAP high-45.49%

AVWAP (52w low)1.31

vs AVWAP low-43.04%

OBV trendDown

Chaikin MF (20)-0.23

Today vs 20d0.40×

Avg vol (14d)140.88K

Avg vol (20d)146.78K

Avg $ vol (20d)136.73K

Market cap3.88M

RS 3m (vs SPY)+186.77%

RS 6m (vs SPY)+189.90%

RS line new highNo

Trend template6/8

Technical rank56.9

1 week-6.88%

1 month-29.72%

3 months+182.73%

6 months+186.98%

1 year-0.12%

YTD+210.55%

P/E-0.21

P/B1.49

P/S—

P/FCF-0.23

EPS-0.4200

Div yield—

ROE-717.15%

ROA-314.01%

Debt/Eq0.02

Current1.59

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-67.06%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value2.46M

Revenue—

Net income-5M

Gross profit—

Free cash flow-16.66M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out5.21M

Employees15

ListedWed, Jan 31, 2024

Free float50.73M

Float %76.3%

Short interest135.59K

Days to cover1.4d

Short volume37.9%

Squeeze score7 / 100

Next earningsThu, Jul 30, 2026 (35d)

EPS forecast−$0.93 · 1 est

Last EPS vs est—

Last surprise—

Setup gradeB

Conviction62 / 100

Pattern quality—

Tech rank56.9 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance1.36

Support0.9312

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in FBLG

All disclosures →

No recent disclosed trades by Congress in FBLG. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in FBLG · 4 buys

Insider	Side	Shares	Value	Traded	Filed
O'HEERON PETE CHIEF EXECUTIVE OFFICER · Stock Option (Right to Buy) · 2026-05-04	Grant	92.41K	$0	2026-05-04	2026-05-04
Khoja Hamid Chief Scientific Officer · Stock Option (Right to Buy) · 2026-05-04	Grant	61.61K	$0	2026-05-04	2026-05-04
Davis Jason Chief Financial Officer · Stock Option (Right to Buy) · 2026-05-04	Grant	61.61K	$0	2026-05-04	2026-05-04
GARCIA RUBEN A General Counsel · Stock Option (Right to Buy) · 2026-05-04	Grant	61.61K	$0	2026-05-04	2026-05-04

SEC filings

EDGAR filings in FBLG · 1 recent

EDGAR →

8-K8-KTue, Jun 23, 2026

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.